AZ, BMS, Lilly, Pfizer make investor's cut
Investor Osman Gulseven finds that of hundreds of healthcare companies listed on the New York Stock Exchange, only four fit his investment objective of high profitability, substantial dividends and a maximum P/E ratio of 20. Each is a large-cap drugmaker: AstraZeneca , Bristol-Myers Squibb, Eli Lilly & Co, and Pfizer. Article
Comments